Eco Science Solutions Q3 2025 Update

TL;DR

**ECO SCIENCE SOLUTIONS (ECSI) Q3 2025 FILING OUT: $50M MARKET CAP, $0.001 SHARE PRICE.**

AI Summary

Eco Science Solutions, Inc. filed a 10-Q for the period ending October 31, 2024. The filing indicates a fiscal year end of January 31st and includes financial data for Q3 2025. Key figures show a potential share price of $0.001 and a market capitalization of $50,000,000.

Why It Matters

This filing provides a snapshot of Eco Science Solutions' financial position and operational data as of October 31, 2024, which is crucial for investors assessing the company's performance.

Risk Assessment

Risk Level: medium — The company has a very low share price and a significant market cap, which could indicate speculative trading or a complex financial structure requiring further investigation.

Key Numbers

• $50,000,000 — Market Capitalization (Indicates the total market value of the company's outstanding shares.)
• $0.001 — Share Price (Represents the trading price per share as of the reporting period.)
• 0131 — Fiscal Year End (Defines the end of the company's annual financial reporting cycle.)

Key Players & Entities

• ECO SCIENCE SOLUTIONS, INC. (company) — Filer
• October 31, 2024 (date) — Reporting Period End Date
• January 31 (date) — Fiscal Year End
• $0.001 (dollar_amount) — Potential Share Price
• $50,000,000 (dollar_amount) — Market Capitalization
• Michael Rountree (person) — Director/Officer
• Ms Jennifer Taylor (person) — Director/Officer
• Ms Meredith Rountree (person) — Director/Officer

FAQ

Filing Documents

• essi_10q.htm (10-Q) — 786KB
• essi_ex31.htm (EX-31) — 11KB
• essi_ex32.htm (EX-32) — 4KB
• essi_10qimg3.jpg (GRAPHIC) — 3KB
• 0001477932-24-008098.txt ( ) — 3448KB
• essi-20241031.xsd (EX-101.SCH) — 35KB
• essi-20241031_lab.xml (EX-101.LAB) — 167KB
• essi-20241031_cal.xml (EX-101.CAL) — 29KB
• essi-20241031_pre.xml (EX-101.PRE) — 152KB
• essi-20241031_def.xml (EX-101.DEF) — 82KB
• essi_10q_htm.xml (XML) — 544KB

– FINANCIAL INFORMATION

PART I – FINANCIAL INFORMATION Item 1.

Financial Statements

Financial Statements 3 Item 2.

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 4 Item 3.

Quantitative and Qualitative Disclosures About Market Risk

Quantitative and Qualitative Disclosures About Market Risk 11 Item 4.

Controls and Procedures

Controls and Procedures 11

– OTHER INFORMATION

PART II – OTHER INFORMATION Item 1.

Legal Proceedings

Legal Proceedings 12 Item 1A.

Risk Factors

Risk Factors 14 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 14 Item 3. Defaults Upon Senior Securities 14 Item 4. Mine Safety Disclosures 14 Item 5. Other Information 14 Item 6. Exhibits 15

SIGNATURES

SIGNATURES 16 2 Table of Contents

-- FINANCIAL INFORMATION

PART I -- FINANCIAL INFORMATION

FINANCIAL STATEMENTS

ITEM 1. FINANCIAL STATEMENTS ECO SCIENCE SOLUTIONS, INC. NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited) Page Unaudited Condensed Consolidated Balance Sheets F-1 Unaudited Condensed Consolidated Statements of Operations F-2 Unaudited Condensed Consolidated Statements of Changes in Stockholders' Equity (Deficit) F-3 Unaudited Condensed Consolidated Statements of Cash Flows F-4 Notes to Unaudited Condensed Consolidated Financial Statements F-5 3 Table of Contents ECO SCIENCE SOLUTIONS, INC. UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS October 31, 2024 January 31, 2024 ASSETS Current assets Cash $ 4,100 $ 2,106 Total current assets 4,100 2,106 Intangible asset 100,000 100,000 TOTAL ASSETS $ 104,100 $ 102,106 LIABILITIES AND STOCKHOLDERS' DEFICIT Current liabilities Accounts payable and accrued expenses $ 4,562,324 $ 4,196,092 Related party payables 3,355,785 3,118,025 Notes payable, short-term, related party 3,849,263 3,632,242 Notes payable 2,960,118 2,960,118 Convertible note, net 1,656,213 1,656,213 Total current liabilities 16,383,703 15,562,690 Total liabilities 16,383,703 15,562,690 Stockholders' deficit Preferred stock, $ 0.001 par, 50,000,000 shares authorized of which 1,000 shares are designated Series A Voting Preferred, none issued and outstanding - - Common stock, $ 0.0001 par, 650,000,000 shares authorized, 53,957,572 shares issued and 52,957,572 shares outstanding 5,396 5,396 Treasury stock ( 1,000,000 shares issued at a cost of $ 0.0075 per share) ( 7,500 ) ( 7,500 ) Additional paid in capital, common, and deferred compensation 62,166,104 62,166,104 Accumulated deficit ( 78,443,603 ) ( 77,624,584 ) Total stockholders' deficit ( 16,279,603 ) ( 15,460,584 ) TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT $ 104,100 $ 102,106 The accompanying notes are an integral part of these unaudited condensed

View Full Filing

View this 10-Q filing on SEC EDGAR